3 Results Found

Advanced Search

Select all

Results per page

Select all

Article

4 Citations

4,232 Views

18 Pages

First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product

Jimena Fernández-Carneado,
Mariona Vallès-Miret,
Sílvia Arrastia-Casado,
Ana Almazán-Moga,
Maria J. Macias,
Pau Martin-Malpartida,
Marta Vilaseca,
Mireia Díaz-Lobo,
Mayte Vazquez and
Berta Ponsati
+ 2 authors

Pharmaceutics2024, 16(4), 537;https://doi.org/10.3390/pharmaceutics16040537

-

13 April 2024

Teriparatide is an anabolic peptide drug indicated for the treatment of osteoporosis. Recombinant teriparatide was first approved in 2002 and has since been followed by patent-free alternatives under biosimilar or hybrid regulatory application. The a...

Full Article

Article

4,348 Views

27 Pages

“Headship”: Making the Case for Fruitful Equality in a World of Indifferent Sameness and Unbridgeable Difference

Margaret Harper McCarthy

Religions2020, 11(6), 295;https://doi.org/10.3390/rel11060295

-

16 June 2020

The article takes up the biblical category of “headship,” one of the “third rails” for Christians in a context dominated by the limited conceptions of equality, especially those assumed by “second wave” and “...

Full Article

Article

6 Citations

7,589 Views

13 Pages

Assessment of “Sameness” and/or Differences between Marketed Creams Containing Miconazole Nitrate Using a Discriminatory in vitro Release Testing (IVRT) Method

Potiwa Purazi,
Seeprarani Rath,
Ashmita Ramanah and
Isadore Kanfer

Sci. Pharm.2020, 88(1), 6;https://doi.org/10.3390/scipharm88010006

-

2 February 2020

In vitro release testing (IVRT) provides an efficient method for the evaluation of drug release from semi-solid formulations. The aim of this research was to develop and validate a discriminatory IVRT system using vertical diffusion cells (VDCs) to a...

Full Article